2018
DOI: 10.1016/j.healun.2018.03.016
|View full text |Cite
|
Sign up to set email alerts
|

Blockade of adhesion molecule lymphocyte function–associated antigen-1 improves long-term heart allograft survival in mixed chimeras

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…A mouse model with pretransplant BMT as well as CD28/B7 and lymphocyte function associated antigen-1 antagonism followed by skin transplantation 4 to 6 weeks after treatment and subsequently heart transplantation 2 weeks later showed induction of long-term donor-specific tolerance of heart allografts, but chronically rejected skin grafts of the same background as the BMT and heart. 17 Although this brings both costimulation blockade and mixed chimerism via BMT closer to clinical relevance, the requirement of receiving a BMT and costimulation treatment 1 to 2 months before a heart transplant remains a significant limitation.…”
Section: Mixed Chimerismmentioning
confidence: 99%
“…A mouse model with pretransplant BMT as well as CD28/B7 and lymphocyte function associated antigen-1 antagonism followed by skin transplantation 4 to 6 weeks after treatment and subsequently heart transplantation 2 weeks later showed induction of long-term donor-specific tolerance of heart allografts, but chronically rejected skin grafts of the same background as the BMT and heart. 17 Although this brings both costimulation blockade and mixed chimerism via BMT closer to clinical relevance, the requirement of receiving a BMT and costimulation treatment 1 to 2 months before a heart transplant remains a significant limitation.…”
Section: Mixed Chimerismmentioning
confidence: 99%